Literature DB >> 1708946

Neuronal and glial properties of a murine transgenic retinoblastoma model.

T Kivelä1, I Virtanen, D M Marcus, J M O'Brien, J L Carpenter, E Brauner, A Tarkkanen, D M Albert.   

Abstract

Antigenic properties of a murine transgenic model for hereditary retinoblastoma, induced by a chimeric gene coding for Simian virus 40 large T antigen, an oncogene that inactivates the retinoblastoma susceptibility gene product, were studied by immunohistochemistry. All transgenic mice develop bilateral intraocular retinal tumors in the inner nuclear layer with Homer Wright-like rosettes, and one quarter develop midbrain tumors resembling trilateral retinoblastoma. Cell lines TE-1 and TM-1 were established from intraocular and metastatic tumors, respectively. Intraocular tumors reacted with antibodies to neuron-specific enolase and synaptophysin, while vimentin, glial fibrillary acidic, and S-100 proteins were detected only in reactive glia derived from adjacent retina. The midbrain tumors showed weak reactivity to synaptophysin, and they blended with reactive astrocytes positive for glial markers. The tumors were negative for cytokeratins. Finally both derived cell lines expressed synaptophysin and individual neurofilament triplet proteins in immunofluorescence and Western blotting, supporting their essentially neuronal nature. The antigenic profile resembles human retinoblastoma, but differences in morphology and antigen distribution suggest a more close relationship to neurons of the inner nuclear layer than to photoreceptor cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708946      PMCID: PMC1886007     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

Review 1.  Diagnostic application of monoclonal antibodies to intermediate filaments.

Authors:  I Virtanen; M Miettinen; V P Lehto; A L Kariniemi; R Paasivuo
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Identification of the conserved, conformation-dependent cytokeratin epitope recognized by monoclonal antibody (lu-5).

Authors:  W W Franke; S Winter; J von Overbeck; F Gudat; P U Heitz; C Stähli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Intermediate filaments in the human retina and retinoblastoma. An immunohistochemical study of vimentin, glial fibrillary acidic protein, and neurofilaments.

Authors:  T Kivelä; A Tarkkanen; I Virtanen
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-07       Impact factor: 4.799

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

6.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

Review 7.  Clues to the cells of origin in retinoblastoma.

Authors:  M O Tso
Journal:  Int Ophthalmol Clin       Date:  1980

8.  Expression of intermediate filaments and synaptophysin show neuronal properties and lack of glial characteristics in Y79 retinoblastoma cells.

Authors:  I Virtanen; T Kivelä; M Bugnoli; C Mencarelli; V Pallini; D M Albert; A Tarkkanen
Journal:  Lab Invest       Date:  1988-11       Impact factor: 5.662

9.  Recurrent medulloepithelioma of the ciliary body. Immunohistochemical characteristics.

Authors:  T Kivelä; A Tarkkanen
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  9 in total

1.  Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Authors:  D M Albert; A E Griep; P F Lambert; K A Howes; J J Windle; J G Lasudry
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 2.  Transgenic Models in Retinoblastoma Research.

Authors:  Rohini M Nair; Geeta K Vemuganti
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

3.  Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma.

Authors:  P Chévez-Barrios; D L Schaffner; R Barrios; P A Overbeek; R M Lebovitz; M W Lieberman
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

4.  Changes in retinoblastoma cell adhesion associated with optic nerve invasion.

Authors:  Nikia Laurie; Adithi Mohan; Justina McEvoy; Damon Reed; Jiakun Zhang; Brett Schweers; Itsuki Ajioka; Virginia Valentine; Dianna Johnson; David Ellison; Michael A Dyer
Journal:  Mol Cell Biol       Date:  2009-09-28       Impact factor: 4.272

5.  Tumor Environment of Retinoblastoma, Intraocular Cancer.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Jeong Hun Kim
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.

Authors:  F Gonzalez-Fernandez; M B Lopes; J M Garcia-Fernandez; R G Foster; W J De Grip; S Rosemberg; S A Newman; S R VandenBerg
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.

Authors:  Andrea A Wenzel; Michael N O'Hare; Mehdi Shadmand; Timothy W Corson
Journal:  Mol Vis       Date:  2015-05-01       Impact factor: 2.367

8.  Insights from mouse models into human retinoblastoma.

Authors:  David Macpherson
Journal:  Cell Div       Date:  2008-05-19       Impact factor: 5.130

9.  Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice.

Authors:  Nisha V Shah; D G Pham; T G Murray; C Decatur; E Hernandez; Nikesh N Shah; M Cavalcante; S K Houston
Journal:  J Ophthalmol       Date:  2014-03-10       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.